200 related articles for article (PubMed ID: 9442979)
1. Posttransplantation lymphoproliferative disorder: changing manifestations of disease in a renal transplant population.
Miller WT; Siegel SG; Montone KT
Crit Rev Diagn Imaging; 1997 Dec; 38(6):569-85. PubMed ID: 9442979
[TBL] [Abstract][Full Text] [Related]
2. Posttransplantation lymphoproliferative disorder: manifestations in pediatric thoracic organ recipients.
Lim GY; Newman B; Kurland G; Webber SA
Radiology; 2002 Mar; 222(3):699-708. PubMed ID: 11867788
[TBL] [Abstract][Full Text] [Related]
3. Imaging features of posttransplantation lymphoproliferative disorder in pancreas transplant recipients.
Meador TL; Krebs TL; Cheong JJ; Daly B; Keay S; Bartlett S
AJR Am J Roentgenol; 2000 Jan; 174(1):121-4. PubMed ID: 10628466
[TBL] [Abstract][Full Text] [Related]
4. Acute renal allograft rejection in patients with Epstein-Barr virus associated post-transplant lymphoproliferative disorder.
Purighalla R; Shapiro R; Jordan ML; Scantlebury VP; Gritsch HA; Vivas C; Randhawa PS
Clin Transplant; 1997 Dec; 11(6):574-6. PubMed ID: 9408687
[TBL] [Abstract][Full Text] [Related]
5. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.
Younes BS; McDiarmid SV; Martin MG; Vargas JH; Goss JA; Busuttil RW; Ament ME
Transplantation; 2000 Jul; 70(1):94-9. PubMed ID: 10919581
[TBL] [Abstract][Full Text] [Related]
6. Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience.
Pinho-Apezzato ML; Tannuri U; Tannuri AC; Mello ES; Lima F; Gibelli NE; Santos MM; Ayoub AA; Maksoud-Filho JG; Velhote MC; Silva MM; Andrade WC; Miyatani HT
Transplant Proc; 2010 Jun; 42(5):1763-8. PubMed ID: 20620519
[TBL] [Abstract][Full Text] [Related]
7. Post-transplant lymphoproliferative disorder in renal allograft recipients. Clinical experience and risk factor analysis in a single center.
Cockfield SM; Preiksaitis JK; Jewell LD; Parfrey NA
Transplantation; 1993 Jul; 56(1):88-96. PubMed ID: 8333073
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathologic study of post-transplant lymphoproliferative disorders].
Zhang YN; Zhou XG; Wang CZ; Wei P; Zhang SH; Zheng YY
Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):209-12. PubMed ID: 16776977
[TBL] [Abstract][Full Text] [Related]
9. Posttransplant lymphoproliferative disorder: intrathoracic manifestations.
Dodd GD; Ledesma-Medina J; Baron RL; Fuhrman CR
Radiology; 1992 Jul; 184(1):65-9. PubMed ID: 1609104
[TBL] [Abstract][Full Text] [Related]
10. Posttransplantation lymphoproliferative disorder of the abdomen: CT evaluation in 51 patients.
Pickhardt PJ; Siegel MJ
Radiology; 1999 Oct; 213(1):73-8. PubMed ID: 10540643
[TBL] [Abstract][Full Text] [Related]
11. Thoracic presentations of posttransplant lymphoproliferative disorders.
Halkos ME; Miller JI; Mann KP; Miller DL; Gal AA
Chest; 2004 Dec; 126(6):2013-20. PubMed ID: 15596707
[TBL] [Abstract][Full Text] [Related]
12. Post-transplant lymphoproliferative disease in liver transplantation.
Dhillon MS; Rai JK; Gunson BK; Olliff S; Olliff J
Br J Radiol; 2007 May; 80(953):337-46. PubMed ID: 17392399
[TBL] [Abstract][Full Text] [Related]
13. Posttransplantation lymphoproliferative disorder in pediatric recipients of solid organ transplants: timing and location of disease.
Wilde GE; Moore DJ; Bellah RD
AJR Am J Roentgenol; 2005 Nov; 185(5):1335-41. PubMed ID: 16247159
[TBL] [Abstract][Full Text] [Related]
14. Posttransplantation lymphoproliferative disorder in children: manifestations in hematopoietic cell recipients in comparison with liver recipients.
Jeon TY; Kim JH; Eo H; Yoo SY; Yoo KH; Lee SK; Lim GY; Cheon JE
Radiology; 2010 Nov; 257(2):490-7. PubMed ID: 20829531
[TBL] [Abstract][Full Text] [Related]
15. Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report.
Miyagi S; Sekiguchi S; Kawagishi N; Akamatsu Y; Satoh K; Takeda I; Fukushima D; Kobayashi Y; Tokodai K; Fujimori K; Satomi S
Transplant Proc; 2011 Nov; 43(9):3299-301. PubMed ID: 22099782
[TBL] [Abstract][Full Text] [Related]
16. Posttransplantation lymphoproliferative disorder associated with OKT3 and decreased antiviral prophylaxis in pancreas transplant recipients.
Keay S; Oldach D; Wiland A; Klassen D; Schweitzer E; Abruzzo LV; Kumar D; Bartlett S
Clin Infect Dis; 1998 Mar; 26(3):596-600. PubMed ID: 9524829
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and prognosis of post-transplant lymphoproliferative disorders within renal allograft: Report from the PTLD.Int. Survey.
Khedmat H; Taheri S
Ann Transplant; 2010; 15(3):80-6. PubMed ID: 20877272
[TBL] [Abstract][Full Text] [Related]
18. A recent decrease in the time to development of monomorphous and polymorphous posttransplant lymphoproliferative disorder.
Alfrey EJ; Friedman AL; Grossman RA; Perloff LJ; Naji A; Barker CF; Montone KT; Tomaszewski JE; Chmielewski C; Holland T
Transplantation; 1992 Aug; 54(2):250-3. PubMed ID: 1323150
[TBL] [Abstract][Full Text] [Related]
19. Focal posttransplantation lymphoproliferative disorder at the renal allograft hilum.
Lopez-Ben R; Smith JK; Kew CE; Kenney PJ; Julian BA; Robbin ML
AJR Am J Roentgenol; 2000 Nov; 175(5):1417-22. PubMed ID: 11044055
[TBL] [Abstract][Full Text] [Related]
20. Central nervous system lymphoproliferative disorder in pediatric kidney transplant recipients.
Traum AZ; Rodig NM; Pilichowska ME; Somers MJ
Pediatr Transplant; 2006 Jun; 10(4):505-12. PubMed ID: 16712612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
